Actively Recruiting
In Vivo Dosimetry for Brachytherapy Study
Led by East and North Hertfordshire NHS Trust · Updated on 2025-03-11
20
Participants Needed
1
Research Sites
51 weeks
Total Duration
On this page
Sponsors
E
East and North Hertfordshire NHS Trust
Lead Sponsor
T
TRUEinvivo Limited
Collaborating Sponsor
AI-Summary
What this Trial Is About
The main study aim is the investigate the clinical use of in vivo dosimeters (small measurement devices) for brachytherapy (internal radiotherapy).
CONDITIONS
Official Title
In Vivo Dosimetry for Brachytherapy Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 years and above
- Patients receiving HDR brachytherapy using iridium-192 radioactive source as monotherapy or combined with external beam radiotherapy for primary or locally recurrent prostate cancer
- Patients receiving HDR brachytherapy using iridium-192 radioactive source as monotherapy or combined with external beam radiotherapy for locally advanced gynaecological malignancy including primary cervix carcinoma FIGO IB2-IVA, vulval FIGO I-IVA, vaginal FIGO I-IVA, endometrial cancer FIGO I-IVA not suitable for surgery, adjuvant vaginal vault brachytherapy for endometrial cancer, or recurrent cervix, vulval, vaginal or endometrial cancer suitable for brachytherapy
- World Health Organisation (WHO) or Eastern Cooperative Oncology Group (ECOG) performance status 0-2
You will not qualify if you...
- Previous brachytherapy exposure to the treatment site
- Patients unable to give informed consent
- Patients unable to have a regional or general anaesthetic
- Patients with coagulopathies, history of another primary malignancy, known allergy or sensitivity to study materials, or previous or current fistulae
- Patients who cannot understand the implications of participating in the study in English
- Patients with recent (within last 6 months) or current participation in interventional research
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mount Vernon Cancer Centre
Northwood, Middlesex, United Kingdom, HA62RN
Actively Recruiting
Research Team
R
Rishma Bhatti
CONTACT
A
Amani Chowdhury
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here